3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with gentamicin in 1 studies
| Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (gentamicin) | Trials (gentamicin) | Recent Studies (post-2010) (gentamicin) |
|---|---|---|---|---|---|
| 36 | 1 | 1 | 19,191 | 1,365 | 3,650 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrend, EN; Fettman, MJ; Getzy, DM; Grauer, GF; Greco, DS; Mani, I; Reinhart, GA | 1 |
1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and gentamicin
| Article | Year |
|---|---|
Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
Topics: Animals; Body Weight; Creatinine; Diet; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Eating; Enzyme Inhibitors; Fatty Acids, Omega-3; Food, Fortified; Gentamicins; Glomerular Filtration Rate; Kidney Cortex; Kidney Diseases; Male; Potassium; Prostaglandins; Protein Synthesis Inhibitors; Pyridines; Random Allocation; Sodium; Thromboxane B2; Thromboxane-A Synthase | 1996 |